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INTRODUCTION 
The World Health Organisation (WHO) defines drug 
utilization as the marketing, distribution, prescription 
and the use of drugs in a society, with special emphasis 
on the resulting medical, social and economic 
consequences 
1
. Rational drug prescribing is the use of 
the least number of drugs to obtain the best possible 
effect in the shortest period and at a reasonable cost 
2
. 
Irrational prescribing and disparity between the 
prescription and the consumption of medicines may 
offset the benefits. The recent proliferation of new 
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drugs and the increasing recognition of delayed 
adverse effects have stimulated interest in the 
prescribing patterns of physicians. Depression is an 
important global public health problem and is a major 
cause of disability and premature death 
3
. With the 
advancement of new drug research and better research 
outcome, psychotropic drug prescribing patterns have 
changed globally over the last few years and limited 
data is available explaining the drug utilization pattern 
and awareness among the psychiatric practitioners. 
Therefore the objective of the present study was to 
observe the prescribing pattern of drugs among 
psychiatrists and to compare the drug utilization 
pattern between a tertiary care teaching hospital and 
private psychiatric practitioners at Dehradun, 
Uttarakhand.    
MATERIALS AND METHOD 
Prescriptions were collected randomly from private 
psychiatric practitioners (PPs) as well as a Tertiary 
Care Teaching Hospital (TCTH) at Dehradun. 
Prescriptions were collected from the OPD during first 
two hours while patients were making their visits. 
Prescriptions were entered in a preformed proforma 
and were analysed on the basis of WHO drug use 
indicators and National List of Essential Medicines 
(NLEM-2013).  
RESULT  
A total number of 371 prescriptions were analysed, of 
which 196 were from PPs and 175 from TCTH. The 
mean age of patients from TCTH was 38.22±1.03 
years while that from PPs was 40.41±1.34 years. Out 
of total 196 patients from PPs, 106 (54.08%) were 
females and 90 (45.92%) were males. Out of total 175 
patients from TCTH, 99 (56.57%) were females and 76 
(43.43%) were males. Majority of patients were 
married (76%, 52.04%) and were housewives (45.14%, 
28.06%) in TCTH and PPs data respectively (Table 1).  
Table 1: Comparison of Demographic profile 
Parameters TCTH 
(n=175) 
PPs (n=196) 
Mean age 38.22±1.03 40.41±1.34 
Age in years   
<18 4 (2.29%) 15 (7.65%) 
18-30 49 (28.0%) 49 (25.0%) 
31-50 93 (53.14%) 79 (40.31%) 
51-70 24 (13.71%) 46 (23.47%) 
>70 5 (2.86%) 7 (3.57%) 
Female:Male 1.30:1 1.17:1 
Married:Unmarried 3.17:1 1.58:1 
Occupation   
Housewife 79 (45.14%) 55 (28.06%) 
Government job 15 (8.57%) 38 (19.39%) 
Businessman 39 (22.29%) 42 (21.43%) 
Student 27 (15.43%) 33 (16.84%) 
Retired 5 (2.86%) 10 (5.10%) 
Unemployed 10 (5.71%) 18 (9.18%) 
 
Table 2: Drug prescribing pattern 
Drug group TCTH 
(n=378) 
PPs (n=594) 
Antianxiety 102 (26.98%) 150 (25.25%) 
Antidepressants 105 (27.78%) 120(20.20%) 
Antipsychotics 37 (9.79%) 111 (18.48%) 
Antiepileptic 30 (7.94%) 92 (15.39%) 
Anticholinergics 11 (2.91%) 6 (1.01%) 
Others 93 (24.60%) 118 (19.67%) 
 
Among the different categories of drugs prescribed, 
anxiolytics 150 (25.25%) were most commonly 
prescribed drug group by the PPs followed by 
antidepressants 120(20.20%) and antipsychotics 111 
(18.48%), whereas antidepressants 105 (27.78%) was 
the major drug group prescribed by TCTH followed by 
anxiolytics 102 (26.98%) and antipsychotics 37 
(9.79%) (Table 2). 
Among 120 antidepressants prescribed by PPs, 
Venlafaxine 37 (30.83%) was the most common one, 
followed by mirtazapine 30 (25%), fluoxetine 21 
(17.5%), escitalopram 19 (15.83%), paroxetine 8 
(6.67%), duloxetine 3 (2.5%) and fluvoxamine 2 
(1.67%). Among 105 antidepressants prescribed by 
TCTH, Amitriptyline 26 (24.76%) constituted major 
group followed by Escitalopram 24 (22.86%), 
venlafaxine 20 (19.04%), fluoxetine 12 (11.43%), 
nortryptyline 7 (6.67%), duloxetine 7 (6.67%) and 
others (Paroxetine, Fluvoxamine, Mirtazapine) (Table 
3).  
Out of total 150 anxiolytics prescribed by PPs, 
alprazolam 89 (59.33%) was most common drug 
prescribed followed by lorazepam 24 (16%), zolpidem 
22 (14.67%) and others (Propranolol, Clonazepam, 
Etiozolam, Ramelteon, Diazepam). Among 102 
anxiolytics prescribed by TCTH, propranolol 44 
(43.14%) was most commonly prescribed followed by 
diazepam 35 (34.31%), clonazepam 18 (17.65%), 
lorazepam 4 (3.92%) and etiozolam 1 (0.98%) (Table 
4).  
Table 3: Most commonly prescribed anti-
depressant drugs 
Drugs TCTH(n=105) PPs(n=120) 
Fluoxetine 12 (11.43%) 21 (17.5%) 
Amitriptyline 26 (24.76%) - 
Escitalopram 24 (22.86%) 19 (15.83%) 
Paroxetine 1 (0.95%) 8 (6.67%) 
Fluvoxamine 3 (2.86%) 2 (1.67%) 
Nortryptyline 7 (6.67%) - 
Venlafaxine 20 (19.04%) 37 (30.83%) 
Duloxetine 7 (6.67%) 3 (2.5%) 
Mirtazapine 5 (4.76%) 30 (25%) 
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Table 4: Prescribing trend of anti-anxiety drugs 
Drugs TCTH(n=102) PPs(n=150) 
Alprazolam - 89 (59.33%) 
Lorazepam 4 (3.92%) 24 (16%) 
Zolpidem - 22 (14.67%) 
Propranolol 44 (43.14%) 5 (3.33%) 
Clonazepam 18 (17.65%) 5 (3.33%) 
Etiozolam 1 (0.98%) 2 (1.33%) 
Ramelteon - 2 (1.33%) 
Diazepam 35 (34.31%) 1 (0.68%) 
 
111 antipsychotics were prescribed by PPs compared 
to 37 prescribed by TCTH. Olanzapine 47 (42.34%) 
was most commonly prescribed followed by 
Risperidone 27 (24.32%), Haloperidol 14 (12.61%), 
Aripiprazole 11 (9.91%), Quetiapine 7 (6.31%), 
Trifluoperazine 3 (2.71%) and Amisulpiride 2 (1.80%). 
Among 37 antipsychotics prescribed by TCTH, 
Risperidone 20 (54.05%) was the most common drug 
prescribed followed by olanzapine 10 (27.03%), 
Levosulpiride 4 (10.81%), Amisulpiride 2 (5.41%) and 
Quetiapine 1 (2.70%) (Table 5).  
Table 5: Prescribing trend of antipsychotics 
Drugs TCTH(n=37) PPs(n=111) 
Olanzapine 10 (27.03%) 47 (42.34%) 
Risperidone 20 (54.05%) 27 (24.32%) 
Aripiprazole - 11 (9.91%) 
Quetiapine 1 (2.70%) 7 (6.31%) 
Amisulpiride 2 (5.41%) 2 (1.80%) 
Levosulpiride 4 (10.81%) - 
Haloperidol - 14 (12.61%) 
Trifluoperazine - 3 (2.71%) 
 
Among the antiepileptics/mood stabilizers prescribed, 
92 were prescribed by PPs of which which, Divalproex 
sodium 41 (44.37%), Lamotrigine 26 (28.26%) and 
Lithium Carbonate 12 (13.04%) were frequently 
prescribed, while, a total of 30 drugs were prescribed 
by TCTH of which Divalproex sodium 25 (83.33%), 
Pregabalin 3 (10%), Lamotrigine 1 (3.33%), and 
Topiramate 1 (3.33%), were commonly prescribed 
(Table 6). 
 
Table 6: Prescribing trend of antiepileptics/mood 
stabilizers 
Drugs TCTH(n=30) PPs(n=92) 
Divalproex sodium 25 (83.33%) 41 (44.37%) 
Pregabalin 3 (10.0%) - 
Lamotrigine 1 (3.33%) 26 (28.26%) 
Lithium Carbonate - 12 (13.04%) 
Levetiracetam - 6 (6.32%) 
Oxcarbazepine - 6 (6.32%) 
Topiramate 1 (3.33%) 1 (1.69%) 
 
The average number of drugs prescribed per 
prescription by PPs was 3.03, while that by TCTH was 
2.16. 100% drugs were prescribed by brand names. 
18.25% Fixed drug combinations (FDCs) were 
prescribed by TCTH while 0% were prescribed by PPs. 
55.39% and 55.56% drugs were prescribed from the 
NLEM-2013 by the PPs and the TCTH respectively 
(Table 8).  
 
Table 7: Most commonly prescribed drugs 
Drug group TCTH (n=378) PPs (n=594) 
Antianxiety Propranolol Alprazolam 
Diazepam Lorazepam 
Antidepressants Amitriptyline Venlafaxine 
Escitalopram Mirtazapine 
Venlafaxine Fluoxetine 
Antipsychotics Risperidone Olanzapine 
Olanzapine Risperidone 
Levosulpiride Haloperidol 
Antiepileptic Divalproex sodium Divalproex sodium 
Pregabalin Lamotrigine 
Anticholinergics Trihexiphenidyl Trihexiphenidyl 
Others Multivitamins Calcium salts 
Non-Steroidal Anti-
Inflammatory Drugs (NSAIDs) 
Multivitamins 
 
Table 8: WHO recommended prescribing indicators 
Parameters TCTH PPs 
Average number of drugs/prescription 2.16 3.03 
Percentage of the drugs prescribed by generic name 0% 0% 
Percentage of fixed drug combinations (FDCs) 18.25% 0% 
Percentage of the drugs prescribed from NLEM 2013 55.56% 55.39% 
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DISCUSSION   
Depression is an important global public health problem 
and is a major cause of disability and premature death 
3
. 
Drug utilization studies are pointers to prescribing 
behaviour of clinicians and help in improving it. A 
prescription therefore may be taken as a reflection of 
the physician’s attitude, whether a private practitioner 
or working in a tertiary care teaching hospital, towards 
the disease and the role of the drug in its treatment 
providing an insight into the nature of the health care 
delivery system. 
 Out of total of 371 prescriptions analysed, 196 from 
PPs and 175 from TCTH, female patients formed the 
majority and is consistent with studies by Grover et al 
and Avanthi et al 
4, 5
. Majority of patients in both TCTH 
and PPs, were in the age group range of 30-51 years in 
both sexes, which is similar to studies by Dutta et al and 
Trivedi et al 
6, 7
. Depression was common among 
housewives in both TCTH and PPs and is comparable to 
previous study 
5
. 
Among the different categories of drugs prescribed at 
TCTH and by PPs, anxiolytics, anti-depressants and 
antipsychotics were the most commonly drug groups 
prescribed which is consistent with previous studies 
4, 7
. 
Out of total antidepressants prescribed by PPs, SSRIs 
(Selective Serotonin Reuptake Inhibitors) were the most 
common followed by SNRIs (Serotonin Norepinephrine 
Reuptake Inhibitors) and atypical antidepressants 
whereas TCAs (Tricyclic Antidepressants) in addition 
to the above groups were prescribed at TCTH. The 
prescribing pattern of antidepressants is consistent with 
previous studies 
8, 9
. This difference in prescribing 
pattern was observed probably due to the fact that 
patients visiting TCTH were from middle to lower 
socioeconomic class and the TCAs are relatively 
cheaper compared to SSRIs. Better tolerability, 
combined with their mild adverse effects, accounts for 
the popularity of SSRIs as the most widely prescribed 
anti-depressants 
5, 10
. Current treatment guidelines 
mostly recommend use of SSRIs as the first line agents 
in patients of depression 
11
. 
Anxiety symptoms are co-morbid with depression and 
benzodiazepines, among anxiolytics, were most 
commonly prescribed at TCTH and by PPs, consistent 
with previous studies 
4, 7
. Newer non-benzodiazepines 
drugs, Zolpidem and Ramelteon were prescribed by PPs 
depicting the increase in awareness and the readiness, to 
use new drugs, among the psychiatric PPs. Another 
reason for higher rate of prescription of benzodiazepine 
by PPs, could be anticipated worsening of anxiety 
which is commonly seen with the use of SSRIs.  
Atypical antipsychotics were frequently prescribed 
compared to the typical or classical antipsychotics at 
TCTH and by PPs, consistent with previous studies 
6, 7, 
9, 12
. Atypical antipsychotics are now rated as first line 
agents since they have low propensity to cause extra-
pyramidal side effects, efficacy against refractory cases, 
better tolerance, low relapse rate, and safer adverse 
effect profile 
12
. Trihexyphenidyl was the most common 
anticholinergic prescribed both at TCTH and by PPs, 
similar to previous studies 
6, 8, 9
. Similar observation was 
observed in a study by Ren et al. where when 
anticholinergic agents were used concomitantly with 
atypical antipsychotics; patients tend to stay on target 
drug significantly longer than those who did not use any 
anticholinergic agents 
13
. 
The average number of drugs per prescription is 
important in psychiatry as polypharmacy and misuse of 
psychotherapeutic drugs is common 
5
. The average 
number of drugs per prescription prescribed by PPs was 
3.03 while at TCTH was 2.16, comparable to studies by 
Lahon et al and Memon et al where 2.32 and 2.72 drugs 
were prescribed per prescription respectively 
2, 14
. 
Although irrational polypharmacy occurs too frequently 
but in many instances it is necessary to manage the 
patient with multiple medications and that makes 
rational polypharmacy. No FDCs were prescribed by 
PPs but 18.25% FDCs were prescribed at TCTH, which 
can be compared to previous studies, in one wherein no 
FDCs were prescribed while in other 91% FDCs were 
prescribed 
2, 5
. Almost equal number of drugs was 
prescribed from the NEML-2013, 55.39% and 55.56% 
by PPs and at TCTH respectively, which is higher 
compared to previous study 
2
. 100% drugs were 
prescribed by their brand names by both PPs and at 
TCTH, which is not in accordance with the WHO 
guidelines, as rational prescribing requires generic 
prescription, suggesting popularity of brands and 
influence of pharmaceutical companies amongst the 
psychiatrists.  
CONCLUSION  
Studying and analysing the prescription patterns seeks 
to monitor, evaluate and help the physicians in 
understanding how the available drugs can be best put 
to use practically. They suggest, if necessary, 
modifications in prescribing patterns so as to make 
medical care rational and our study was a step in that 
direction. In the present study, it was difficult to come 
to a specific conclusion on rational prescribing in the 
prescriptions collected from the PPs and TCTH. There 
were lesser number of drugs prescribed per prescription 
and more frequent use of drug combinations at TCTH 
while no drug combinations and greater number of 
drugs per prescription were prescribed by PPs. Newer 
class of drugs were being increasingly prescribed by 
PPs, SSRIs as antidepressants and non-benzodiazepine 
anxiolytics, zolpidem and ramelteon. This study may 
help to identify the problems involved in therapeutic 
decision making, among the psychiatric practitioners 
based on which future research studies could be 
contemplated to promote rational prescribing.  
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